TY - JOUR T1 - Risk of meningioma with medicines containing nomegestrol JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 148 LP - 148 DO - 10.1136/dtb.2022.000048 VL - 60 IS - 10 A2 - , Y1 - 2022/10/01 UR - http://dtb.bmj.com/content/60/10/148.abstract N2 - Overview of: European Medicines Agency. Medicines containing nomegestrol or chlormadinone: PRAC recommends new measures to minimise risk of meningioma [online], 2022. Available: https://www.ema.europa.eu/en/medicines/human/referrals/nomegestrol-chlormadinone [Accessed 24 Aug 2022]. ER -